GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...

Piling into the GLP-1 space There is also continued activity in obesity and diabetes following the runaway success of Novo Nordisk’s Wegovy (semaglutide ... 50 other mechanisms of action ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

IDAHO, USA — Over 2,000 demonstrators gathered at the Idaho State Capitol on Saturday as part of the 50501 movement's "National Day of Action," with similar protests occurring simultaneously in ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help ... reduce craving for alcohol and nicotine via a similar mechanism to its ability to reduce food cravings and help people ...

This administration’s disregard for climate research, action and education is not just harming the environment — it’s no doubt exacerbating Bay Area residents’ mounting climate anxiety.

Since then, he has been covering stories in science and tech. Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but can be serious, a new study found ...